Charlotte Coles
#180,134
Most Influential Person Now
British oncologist
Charlotte Coles's AcademicInfluence.com Rankings
Charlotte Colesmedical Degrees
Medical
#3728
World Rank
#4233
Historical Rank
Oncology
#267
World Rank
#276
Historical Rank
Charlotte Colesphilosophy Degrees
Philosophy
#11792
World Rank
#16293
Historical Rank
Logic
#8597
World Rank
#10778
Historical Rank
Download Badge
Medical Philosophy
Charlotte Coles's Degrees
- Masters Medicine University of Oxford
Why Is Charlotte Coles Influential?
(Suggest an Edit or Addition)According to Wikipedia, Charlotte E. Coles is a British oncologist and professor at the University of Cambridge Her research focuses on using personalised radiation therapy for people with breast cancer. In 2019 she was awarded a Research Professorship at the National Institute for Health Research .
Charlotte Coles's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Normal tissue reactions to radiotherapy: towards tailoring treatment dose by genotype (2009) (617)
- Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial (2020) (406)
- Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial (2020) (406)
- Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer (2013) (377)
- Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial (2017) (359)
- Independent validation of genes and polymorphisms reported to be associated with radiation toxicity: a prospective analysis study. (2012) (212)
- Randomized controlled trial of intensity-modulated radiotherapy for early breast cancer: 5-year results confirm superior overall cosmesis. (2013) (193)
- Recommendations for standardized pathological characterization of residual disease for neoadjuvant clinical trials of breast cancer by the BIG-NABCG collaboration. (2015) (163)
- Hypofractionated whole-breast radiotherapy for women with early breast cancer: myths and realities. (2011) (151)
- Acute skin toxicity associated with a 1-week schedule of whole breast radiotherapy compared with a standard 3-week regimen delivered in the UK FAST-Forward Trial (2016) (144)
- A genome wide association study (GWAS) providing evidence of an association between common genetic variants and late radiotherapy toxicity. (2014) (135)
- Randomized controlled trial of forward-planned intensity modulated radiotherapy for early breast cancer: interim results at 2 years. (2012) (127)
- A randomised controlled trial of forward-planned radiotherapy (IMRT) for early breast cancer: baseline characteristics and dosimetry results. (2009) (121)
- Clinical impact of computed tomography-based image-guided brachytherapy for cervix cancer using the tandem-ring applicator - the Addenbrooke's experience. (2009) (106)
- Radiogenomics: radiobiology enters the era of big data and team science. (2014) (96)
- Individual patient data meta-analysis shows a significant association between the ATM rs1801516 SNP and toxicity after radiotherapy in 5456 breast and prostate cancer patients. (2016) (92)
- Practice-changing radiation therapy trials for the treatment of cancer: where are we 150 years after the birth of Marie Curie? (2018) (87)
- A replicated association between polymorphisms near TNFα and risk for adverse reactions to radiotherapy (2012) (76)
- The Cambridge Breast Intensity-modulated Radiotherapy Trial: patient- and treatment-related factors that influence late toxicity. (2011) (74)
- Establishment of a Radiogenomics Consortium. (2010) (74)
- The requirements of a specialist breast centre (2020) (72)
- Relationship between irradiated breast volume and late normal tissue complications: a systematic review. (2012) (69)
- Titanium clip placement to allow accurate tumour bed localisation following breast conserving surgery: audit on behalf of the IMPORT Trial Management Group. (2008) (69)
- Individual patient data meta-analysis shows no association between the SNP rs1800469 in TGFB and late radiotherapy toxicity. (2012) (69)
- A Dosimetric Comparison of Breast Radiotherapy Techniques to Treat Locoregional Lymph Nodes Including the Internal Mammary Chain. (2018) (64)
- Standardized Total Average Toxicity score: a scale- and grade-independent measure of late radiotherapy toxicity to facilitate pooling of data from different studies. (2012) (64)
- Target volume definition for external beam partial breast radiotherapy: clinical, pathological and technical studies informing current approaches. (2010) (61)
- Clinical impact of IMPORT HIGH trial (CRUK/06/003) on breast radiotherapy practices in the United Kingdom. (2015) (61)
- ESTRO ACROP consensus guideline for target volume delineation in the setting of postmastectomy radiation therapy after implant-based immediate reconstruction for early stage breast cancer. (2019) (60)
- XRCC1 Polymorphism Associated With Late Toxicity After Radiation Therapy in Breast Cancer Patients. (2015) (60)
- No association between SNPs regulating TGF-β1 secretion and late radiotherapy toxicity to the breast: results from the RAPPER study. (2010) (60)
- Reduction of radiotherapy-induced late complications in early breast cancer: the role of intensity-modulated radiation therapy and partial breast irradiation. Part II--Radiotherapy strategies to reduce radiation-induced late effects. (2005) (58)
- It's PRIMETIME. Postoperative Avoidance of Radiotherapy: Biomarker Selection of Women at Very Low Risk of Local Recurrence. (2016) (55)
- Reduction of radiotherapy-induced late complications in early breast cancer: the role of intensity-modulated radiation therapy and partial breast irradiation. Part I--normal tissue complications. (2005) (54)
- Prevention of pegfilgrastim-induced bone pain: a phase III double-blind placebo-controlled randomized clinical trial of the university of rochester cancer center clinical community oncology program research base. (2012) (54)
- Quantitative assessment of inter-clinician variability of target volume delineation for medulloblastoma: quality assurance for the SIOP PNET 4 trial protocol. (2003) (51)
- An audit of delays before and during radical radiotherapy for cervical cancer--effect on tumour cure probability. (2003) (50)
- Association of breast tumour bed seroma with post-operative complications and late normal tissue toxicity: results from the Cambridge Breast IMRT trial. (2012) (46)
- European Society for Radiotherapy and Oncology Advisory Committee in Radiation Oncology Practice consensus recommendations on patient selection and dose and fractionation for external beam radiotherapy in early breast cancer. (2022) (46)
- Characterization of target volume changes during breast radiotherapy using implanted fiducial markers and portal imaging. (2009) (46)
- Preoperative breast radiation therapy: Indications and perspectives. (2017) (43)
- Patient-Reported Outcomes Over 5 Years After Whole- or Partial-Breast Radiotherapy: Longitudinal Analysis of the IMPORT LOW (CRUK/06/003) Phase III Randomized Controlled Trial (2018) (42)
- Nausea and disturbed sleep as predictors of cancer-related fatigue in breast cancer patients: a multicenter NCORP study (2017) (41)
- Normal tissue complication probability (NTCP) parameters for breast fibrosis: pooled results from two randomised trials. (2013) (41)
- Tumour bed delineation for partial breast/breast boost radiotherapy: what is the optimal number of implanted markers? (2013) (41)
- High definition three-dimensional ultrasound to localise the tumour bed: a breast radiotherapy planning study. (2007) (40)
- Evaluation of implanted gold seeds for breast radiotherapy planning and on treatment verification: a feasibility study on behalf of the IMPORT trialists. (2011) (37)
- Patient reported outcome measures (PROMs) following forward planned field-in field IMRT: results from the Cambridge Breast IMRT trial. (2014) (36)
- Axillary Surgery Following Neoadjuvant Chemotherapy - Multidisciplinary Guidance From the Association of Breast Surgery, Faculty of Clinical Oncology of the Royal College of Radiologists, UK Breast Cancer Group, National Coordinating Committee for Breast Pathology and British Society of Breast Radio (2019) (34)
- Abstract GS4-02: Regional lymph node irradiation in early stage breast cancer: An EBCTCG meta-analysis of 13,000 women in 14 trials (2019) (33)
- Simultaneous Space Diffusivity and Source Term Reconstruction in 2D IHCP (2001) (32)
- Radiation Fractionation Schedules Published During the COVID-19 Pandemic: A Systematic Review of the Quality of Evidence and Recommendations for Future Development (2020) (32)
- Planning with intensity-modulated radiotherapy and tomotherapy to modulate dose across breast to reflect recurrence risk (IMPORT High trial). (2011) (31)
- Breast radiotherapy: less is more? (2013) (29)
- Titanium clip placement to allow accurate tumour bed localisation following breast conserving surgery – audit on behalf of the IMPORT Trial Management Group (2008) (27)
- Spontaneous fracture and embolization of a central venous catheter: prevention and early detection. (1998) (26)
- How does imaging frequency and soft tissue motion affect the PTV margin size in partial breast and boost radiotherapy? (2012) (25)
- The Cambridge post-mastectomy radiotherapy (C-PMRT) index: a practical tool for patient selection. (2013) (24)
- Early radiotherapy dose response and lack of hypersensitivity effect in normal brain tissue: a sequential dynamic susceptibility imaging study of cerebral perfusion. (2007) (23)
- The Financial Impact on Reimbursement of Moderately Hypofractionated Postoperative Radiation Therapy for Breast Cancer: An International Consortium Report. (2020) (22)
- The use of moderately hypofractionated post-operative radiation therapy for breast cancer in clinical practice: A critical review (2020) (20)
- Breast cancer management pathways during the COVID-19 pandemic: outcomes from the UK ‘Alert Level 4’ phase of the B-MaP-C study (2020) (19)
- The 2016 Assisi Think Tank Meeting on breast cancer: white paper (2016) (18)
- Concurrent weekly cisplatin chemotherapy and radiotherapy in a haemodialysis patient with locally advanced cervix cancer. (2008) (17)
- Patients with a High Polygenic Risk of Breast Cancer do not have An Increased Risk of Radiotherapy Toxicity (2015) (17)
- Identification of parameters in the 2-D IHCP (2000) (16)
- 7LBA A 5-fraction regimen of adjuvant radiotherapy for women with early breast cancer: first analysis of the randomised UK FAST trial (ISRCTN62488883, CRUKE/04/015) (2009) (16)
- The Cambridge Breast Intensity-modulated Radiotherapy Trial: Comparison of Clinician- versus Patient-reported Outcomes. (2016) (15)
- The use of bolus in postmastectomy radiation therapy for breast cancer: A systematic review. (2021) (15)
- The Assisi Think Tank Meeting and Survey of post MAstectomy Radiation Therapy after breast reconstruction: The ATTM-SMART report. (2018) (15)
- Does participation in clinical trials influence the implementation of new techniques? A look at changing techniques in breast radiotherapy in the UK. (2012) (15)
- Can patient-reported outcomes be used instead of clinician-reported outcomes and photographs as primary endpoints of late normal tissue effects in breast radiotherapy trials? Results from the IMPORT LOW trial (2019) (14)
- A Delphi study and International Consensus Recommendations: The use of bolus in the setting of postmastectomy radiation therapy for early breast cancer. (2021) (13)
- OC-0595: FAST-Forward phase 3 RCT of 1-week hypofractionated breast radiotherapy:3-year normal tissue effects (2018) (12)
- The effect of image guidance on dose distributions in breast boost radiotherapy. (2014) (11)
- Abstract GS4-05: Dose escalated simultaneous integrated boost radiotherapy for women treated by breast conservation surgery for early breast cancer: 3-year adverse effects in the IMPORT HIGH trial (CRUK/06/003) (2019) (11)
- Breast cancers: noninvasive method of preoperative localization with three-dimensional US and surface contour mapping. (2007) (11)
- A Randomised Controlled Trial of Forward-Planned Intensity Modulated Radiotherapy (IMRT) for Early Breast Cancer: Interim Results at 2 Years Follow-Up. (2009) (11)
- Can Interrogation of Tumour Characteristics Lead us to Safely Omit Adjuvant Radiotherapy in Patients with Early Breast Cancer? (2018) (10)
- Treatment of the axilla in patients with primary breast cancer and low burden axillary disease: Limitations of the evidence from randomised controlled trials. (2017) (10)
- Breast Cancer Demographics, Types and Management Pathways: Can Western Algorithms be Optimally used in Eastern Countries? (2019) (9)
- The NeST (Neoadjuvant systemic therapy in breast cancer) study: National Practice Questionnaire of United Kingdom multi-disciplinary decision making (2020) (9)
- P15 The IMPORT Gold Seed Study: Evaluation of Tumour Bed Localisation and Image-guided Radiotherapy for Breast Cancer (2007) (9)
- A multicentre observational study evaluating image-guided radiotherapy for more accurate partial-breast intensity-modulated radiotherapy: comparison with standard imaging technique (2014) (9)
- Parameter estimation for a drying system in a porous medium (2006) (9)
- Treatment of Regional Lymph Nodes in Breast Cancer-Evidence in Favor of Radiation Therapy. (2016) (8)
- Accelerated partial breast irradiation: the new standard? (2016) (8)
- The 2018 assisi think tank meeting on breast cancer: International expert panel white paper. (2020) (8)
- Preoperative radiation therapy: The 'new' targeted breast cancer treatment? (2017) (7)
- Consensus on target volume delineation and treatment planning strategy for the DBCG RT Recon trial (2018) (6)
- The Assisi Think Tank Meeting Survey of post-mastectomy radiation therapy in ductal carcinoma in situ: Suggestions for routine practice. (2019) (6)
- Is breast seroma after tumour resection associated with patient-reported breast appearance change following radiotherapy? Results from the IMPORT HIGH (CRUK/06/003) trial (2019) (6)
- External Validation of a Predictive Model for Acute Skin Radiation Toxicity in the REQUITE Breast Cohort (2020) (6)
- The NeST (neoadjuvant systemic therapy in breast cancer) study – Protocol for a prospective multi-centre cohort study to assess the current utilization and short-term outcomes of neoadjuvant systemic therapies in breast cancer (2019) (6)
- Definition of Tumor Bed Boost in Oncoplastic Breast Surgery: An Understanding and Approach (2019) (6)
- Accelerated partial breast irradiation: more questions than answers? (2019) (6)
- A multicentre study of the evidence for customized margins in photon breast boost radiotherapy (2015) (5)
- The SMALL Trial: A Big Change for Small Breast Cancers. (2019) (5)
- Automatic numerical solution of generalized 2-D IHCP by discrete mollification (1999) (5)
- Prevention of pegfilgrastim-induced bone pain (PIP): A URCC CCOP randomized, double-blind, placebo-controlled trial of 510 cancer patients. (2010) (5)
- The B-MaP-C study: Breast cancer management pathways during the COVID-19 pandemic. Study protocol (2020) (5)
- Parameter identification using mollification for predator-prey models in spatially heterogeneous environments (2004) (4)
- Optimization and comparison of balloon-based partial breast brachytherapy using a single source, a standard plan line source, and both forward and inverse planned multilumen techniques. (2013) (4)
- The IMPORT HIGH image-guided radiotherapy study: a model for assessing image-guided radiotherapy. (2015) (4)
- COVID-19: A Catalyst for Change for UK Clinical Oncology (2020) (4)
- Radiotherapy research trials in the UK: secrets of success. (2012) (4)
- Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer (2013) (3)
- The Breast Cancer Trainees Research Collaborative Group: A New Multidisciplinary Network to Facilitate Breast Cancer Research. (2020) (3)
- Current practice and surgical outcomes of neoadjuvant chemotherapy for early breast cancer: UK NeST study. (2022) (3)
- Survivorship Issues in Radiation Oncology. (2015) (3)
- Publisher Correction: Breast cancer management pathways during the COVID-19 pandemic: outcomes from the UK ‘Alert Level 4’ phase of the B-MaP-C study (2021) (3)
- Intensity-modulated Radiotherapy for the Treatment of Breast Cancer. (2013) (3)
- When the World Throws You a Curve Ball: Lessons Learned in Breast Cancer Management. (2021) (3)
- Parameter estimation in the 1-D transport equation with advection (2002) (3)
- Correction: Breast cancer management pathways during the COVID-19 pandemic: outcomes from the UK ‘Alert Level 4’ phase of the B-MaP-C study (2021) (3)
- Lifelong learning in clinical oncology editorial series: introduction and overview. (2011) (2)
- Another piece in the jigsaw of accelerated partial breast irradiation. (2017) (2)
- A longitudinal analysis of patient reported outcomes over 5 years in the IMPORT LOW (partial breast radiotherapy after breast conservation surgery) phase III randomised controlled trial (2018) (2)
- The Radiotherapy Clinical Trial Research Landscape in the UK Between 2004 and 2013: A Cross-sectional Analysis. (2015) (2)
- The Lancet Breast Cancer Commission: tackling a global health, gender, and equity challenge (2022) (2)
- The Lancet Breast Cancer Commission: tackling a global health, gender, and equity challenge (2022) (2)
- Radiotherapy Trial Set-up in the UK: Identifying Inefficiencies and Potential Solutions. (2020) (2)
- No association between polygenic risk scores for cancer and development of radiotherapy toxicity. (2022) (2)
- ESTRO consensus guideline for target volume delineation in the setting of postmastectomy radiation therapy after implant-based immediate reconstruction for early stage breast cancer (2019) (2)
- Conformal Radiotherapy Facilitates the Delivery of Concurrent Chemotherapy and Radiotherapy: A Case of Primitive Neuroectodermal Tumour of the Chest Wall (2000) (2)
- Breast radiotherapy for ductal carcinoma in situ: could less be more? (2022) (1)
- Abstract P6-12-04: Does the addition of a patient decision aid video reduce decisional conflict in patients considering a de-escalation of radiotherapy trial? Results from the PRIMETIME study (2020) (1)
- Can patient decision aids reduce decisional conflict in a de-escalation of breast radiotherapy clinical trial? The PRIMETIME Study Within a Trial implemented using a cluster stepped-wedge trial design (2021) (1)
- Targeted radiotherapy for early breast cancer – Authors' reply (2018) (1)
- Abstract OT2-05-01: The HER2-RADiCAL study (Response ADaptive CAre pLan) - Tailoring treatment for HER2 positive early breast cancer (2022) (1)
- Cost-effectiveness of 5 fraction and partial breast radiotherapy for early breast cancer in the UK: model-based multi-trial analysis (2022) (1)
- Gynaecological Oncology: Radiotherapy for gynaecological cancers (2009) (1)
- A multi-institutional investigation of image-guided radiotherapy for breast cancer (2014) (1)
- OC-0156: Concordance of patient reported outcomes with clinician and photographic assessments in IMPORT LOW (2018) (1)
- OC-0610: FAST-Forward phase 3 RCT of 1-week hypofractionated breast radiotherapy: 5-year results (2020) (1)
- FAST-Forward Phase III Randomised Controlled Trial of 1-Week Hypofractionated Breast Radiotherapy: 5-Year Results for Efficacy and Late Normal Tissue Effects (2020) (1)
- Numerical solutions of inverse spatial Lotka-Volterra systems (2005) (1)
- Partial breast radiotherapy after breast conservation surgery for early breast cancer: 5-year outcomes from the IMPORT LOW (CRUK/06/003) phase III randomised controlled trial (2017) (1)
- SP-0477: Where should we place radiotherapy: before or after surgery? (2017) (1)
- O-17 Implanted gold seeds for tumour bed localisation and image-guided radiotherapy (2007) (1)
- Association between cancer-related fatigue and other symptoms in breast cancer patients. (2013) (1)
- SP-0314: Partial breast radiotherapy after breast conservation: 5 year outcomes from the IMPORT LOW (CRUK/06/003) phase III trial (2017) (1)
- Abstract OT1-06-02: SMALL - Open surgery versus minimally invasive vacuum-assisted excision for small screen detected breast cancer: A phase 3 randomised trial (2022) (1)
- The landscape of systemic regimens used routinely in the neoadjuvant setting in the UK: the NEST national prospective multi-centre cohort study (2020) (0)
- Abstract P3-08-09: Is it me or is it hot in here? Hot flushes (or flashes): An unmet need. UK NCRI breast clinical studies group working party on symptom management (vasomotor) (2013) (0)
- 622 poster OPTIMISATION OF MAMMOSITE BRACHYTHERAPY (2011) (0)
- Abstract ES4-1: Partial breast irradiation: Efficacy and patient selection (2019) (0)
- Equity, diversity, and inclusion in radiation oncology: a bibliometric analysis and critical review. (2023) (0)
- Abstract OT3-20-02: SMALL: Open Surgery versus Minimally invasive vacuum-Assisted excision for smaLL screen-detected breast cancer – a UK phase III randomised multi-centre trial (2023) (0)
- 1178 poster EVALUATION OF THE EFFECT OF TUMOUR BED MARKER MOVEMENT UPON PATIENT SET-UP ACCURACY DURING BREAST RADIOTHERAPY (2011) (0)
- Abstract P2-16-04: National utilisation of neoadjuvant systemic therapy and impact on surgical treatment - A prospective multi-centre cohort study (2020) (0)
- Abstract P6-05-17: Recruitment challenges in a UK surgical de-escalation study: preliminary qualitative research findings from the SMALL trial (2023) (0)
- 54: International Expert Delphi Consensus Guidelines for the Use of Bolus in Post Mastectomy Radiation Therapy (2021) (0)
- Background, stage distribution at presentation and indications for radiotherapy (2011) (0)
- Do Polygenic Risk Scores For Cancer Susceptibility Associate With Risk Of Radiotherapy Toxicity? (2020) (0)
- The effect of patient and treatment characteristics on set-up accuracy (2014) (0)
- Understanding radiotherapy and its potential for use in novel combination trials Breast cancer (2012) (0)
- Clinical Oncology: Past, Present and Future (2015) (0)
- Development of three-dimensional radiotherapy techniques in breast cancer (2005) (0)
- OC-0075: Normal tissue complication probability parameters for breast fibrosis: pooled results from two randomised trials (2013) (0)
- Current controversies in breast cancer: do we have the answers? (2013) (0)
- Can patient decision aids reduce decisional conflict in a de-escalation of breast radiotherapy clinical trial? The PRIMETIME Study Within a Trial implemented using a cluster stepped-wedge trial design. (2021) (0)
- OC-0202: A randomised controlled trial of intensity modulated radiotherapy (IMRT) for early breast cancer: results at 5 years (2013) (0)
- Breast (Chapter 4) (2006) (0)
- SA 6.1 Patient selection, dose and fractionation for external beam radiotherapy in patients with early breast cancer (2023) (0)
- The current management of vasomotor symptoms in breast cancer patients in the UK : clinician versus patient perspective. NCRI Breast CSG Working Party on Symptom Management (Vasomotor) (2014) (0)
- PO-0842: Choosing the best heart sparing technique for breast and internal mammary chain radiotherapy (2017) (0)
- Coverage of axillary lymph node levels using standard radiotherapy fields for breast cancer patients – what are we actually treating? (2016) (0)
- Development and validation of a predictive risk model for acute skin toxicity in patients undergoing breast radiotherapy (2017) (0)
- Practice-changing radiation therapy trials for the treatment of cancer: where are we 150 years after the birth of Marie Curie? (2018) (0)
- O-112 The Cambridge Breast Intensity Modulated Radiotherapy Trial: dosimetry results for 1089 patients (2007) (0)
- Reasons for Undergoing CT During Childhood: Is the Population Comparable to the Population with No Experience of CT? (2020) (0)
- Radiotherapy in early breast cancer (2005) (0)
- A gap analysis for breast cancer research: identifying translational priorities (2013) (0)
- OC-0369 QUALITY OF LIFE IN EARLY BREAST CANCER: RESULTS FROM CAMBRIDGE BREAST INTENSITY-MODULATED RADIOTHERAPY TRIAL (2012) (0)
- The impact of surface roughness geometry on aero-engine intakes at incidence (2018) (0)
- SP-0003: Partial Breast Irradiation: who, when and how? (2016) (0)
- Correction: The Impact of Surface Roughness Geometry on Aero-Engine Intakes at Incidence (2018) (0)
- 85: The Use of Bolus in Postmastectomy Radiation Therapy for Breast Cancer: A Systematic Review (2021) (0)
- The Cambridge Breast IMRT trial: comparison of clinician versus patient reported outcomes (2017) (0)
- Breast radiotherapy (2019) (0)
- The impact of surface roughness on transonic inlet lip-flows at incidence (2019) (0)
- 516 oral ASSOCIATION OF BREAST TUMOUR BED SEROMA WITH POSTOPERATIVE INFECTION AND LATE NORMAL TISSUE TOXICITY: RESULTS FROM THE CAMBRIDGE BREAST IMRT TRIAL (2011) (0)
- ATM rs1801516 SNP and toxicity after radiotherapy (2017) (0)
- 394 poster IMPORT-LOW PARTIAL BREAST OUTLINING STUDY: USE OF A TRAINING PROTOCOL TO IMPROVE INTER-OBSERVER CONCORDANCE (2011) (0)
- 116 A validation study of 68 single nucleotide polymorphisms which have been associated with radiation toxicity: preliminary results of the RAPPER study (2010) (0)
- Targeted radiotherapy for early breast cancer reply (2018) (0)
- Ways to improve breast cancer patients' management and clinical outcome: The 2020 Assisi Think Tank Meeting. (2022) (0)
- Review : relationship between irradiated breast volume and late normal tissue complications (2013) (0)
- IMPORT LOW: in response to Vaidya et al (2018) (0)
- The NeST (Neoadjuvant systemic therapy in breast cancer) study: National Practice Questionnaire of United Kingdom multi-disciplinary decision making (2021) (0)
- A critical review of the relationship between irradiated breast volume and late breast tissue complications (2014) (0)
- Surgical outcomes following neoadjuvant chemotherapy: a UK national prospective multi-centre cohort study (2020) (0)
- Proton Beam Therapy for Early Breast Cancer: A Systematic Review and Meta-analysis of Clinical Outcomes. (2023) (0)
- Unanswered Questions Concerning Locoregional Irradiation in Breast Cancer-Reply. (2017) (0)
- SMALL: Open surgery versus minimally invasive vacuum-assisted excision for small screen-detected breast cancers. (2022) (0)
- Internal mammary node irradiation in breast cancer: does benefit outweigh risk? (2020) (0)
- POSTER DISCUSSION: 9: CLINICAL: BREASTPD-0322: The Cambridge post-mastectomy radiotherapy (C-PMRT) index: a practical tool for patient selection (2013) (0)
- Corrigendum to: Current practice and surgical outcomes of neoadjuvant chemotherapy for early breast cancer: UK NeST study. (2022) (0)
- Prospective assessment of symptom burden among cancer survivors with common solid tumors: Results from ECOG trial E2Z02. (2011) (0)
- OC-0595 Does seroma predict patient-reported adverse effects following breast radiotherapy in IMPORT HIGH? (2019) (0)
- UK Interdisciplinary Breast Cancer Symposium 2020 (2020) (0)
- 660 poster PRELIMINARY RESULTS OF MRI-BASED IMAGE-GUIDED BRACHYTHERAPY FOR CERVIX CANCER – THE ADDENBROOKE'S EXPERIENCE (2011) (0)
- OC-0452: Evaluation of a novel field placement algorithm for tangential internal mammary chain radiotherapy (2017) (0)
- Individual patient data meta-analysis shows a significant association between the ATM rs1801516 SNP and toxicity after radiotherapy in 5,456 breast and prostate cancer patients (2017) (0)
- O-49 The influence of patient-related and surgical factors on overall cosmesis and late toxicity after adjuvant breast radiotherapy: Results from the Cambridge Intensity Modulated Radiotherapy (IMRT) Trial (2010) (0)
- Proton Beam Therapy in Breast Cancer Patients: The UK PARABLE Trial is Recruiting. (2023) (0)
- Use of tumour bed boost radiotherapy in volume replacement oncoplastic breast surgery: A systematic review. (2023) (0)
- Hamlet.rt Trans: a prospective single-centre translational sub-study evaluation of liquid biomarkers of radiation response (2023) (0)
- The impact of roughness size on the shock-wave boundary-layer interaction on aero-engine intakes at incidence. (2019) (0)
- Abstract P6-12-10: Method development for a ‘Study within a Trial’ using a cluster stepped wedge trial design: Evaluating a patient decision aid video on patients’ decisional conflict in the PRIMETIME study (2020) (0)
- SP-0003: Optimal Sequence in the treatment of breast cancer: RT first? (2018) (0)
- Normal-tissue complication modelling for breast tissue (2014) (0)
- Partial or whole breast radiotherapy after breast-conserving surgery? (2020) (0)
- Partial breast irradiation (2013) (0)
- Accumulating long-term evidence for partial breast irradiation. (2023) (0)
- Bridging pre-surgical endocrine therapy for breast cancer during the COVID-19 pandemic: outcomes from the B-MaP-C study (2023) (0)
- 468 Forward Planning Versus Inverse Planning of Multi-lumen MammoSite Brachytherapy (2012) (0)
- EP-1784: Clinical impact of IMPORT HIGH trial (CRUK/06/003) on breast radiotherapy in the United Kingdom (2014) (0)
This paper list is powered by the following services:
Other Resources About Charlotte Coles
What Schools Are Affiliated With Charlotte Coles?
Charlotte Coles is affiliated with the following schools:
